Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.

AIMS: Ivabradine has been approved in heart failure with reduced ejection fraction (HFrEF) and elevated heart rate despite guideline‐directed medical therapy (GDMT) to reduce cardiovascular (CV) death and hospitalization for worsening HF. The median value of 77 b.p.m. is the lower bound selected for...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouabdallaoui, Nadia, O'Meara, Eileen, Bernier, Virginie, Komajda, Michel, Swedberg, Karl, Tavazzi, Luigi, Borer, Jeffrey S., Bohm, Michael, Ford, Ian, Tardif, Jean‐Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989297/
https://www.ncbi.nlm.nih.gov/pubmed/31591826
http://dx.doi.org/10.1002/ehf2.12513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989297/
https://www.ncbi.nlm.nih.gov/pubmed/31591826
http://dx.doi.org/10.1002/ehf2.12513

Ejemplares similares